弘達金融控股(01822.HK)建議削減已發行股份股本及拆細未發行股份
格隆匯5月27日丨弘達金融控股(01822.HK)公佈,於股份合併生效及供股完成後,實施股本削減,涉及以註銷公司繳足股本(以每股已發行合併股份註銷0.19港元為限)的方式,將每股已發行合併股份的面值由0.20港元減至0.01港元,以削減公司已發行股本。因股本削減而產生的進賬將用於抵銷公司於生效日期的累計虧絀,從而減少公司的累計虧絀。進賬餘額(如有)將轉撥至公司的可分派儲備賬及就所有適用法例及公司的組織章程大綱及細則所准許的目的及按董事會認為合適的情況動用。
緊接股本削減生效後,每股法定但未發行合併股份將拆細為20股每股面值0.01港元的經調整股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.